5.3 million: the number of Americans that suffer from Alzheimer’s disease.
Parkinson’s patients lose 25 million per year in lost wages because of symptoms.
These are the black and white numbers. What isn’t so black and white is the quality of life experienced by those who suffer every day with Alzheimer’s and Parkinson’s disease. Both diseases are caused by neuron destroying goo called plaques that rob the quality of life. Alzheimer’s disease has been linked to Beta amyloid and tau proteins while alpha- synuclein is linked to Parkinson’s. The structure of the proteins is compromised by a kink in the folding process that causes plaques.
Both diseases overlap in how the plaques are formed which has made it possible to study a new drug called M13 that targets plaque formation. In mice with Alzheimer’s and Parkinson’s plaques, the M13 treatment decreased all three protein levels. Researchers at NeuroPhage believe M13 could also be used to treat other neurodegenerative disorders.
Read more at www.newscientist.com/article/dn27921-universal-plaque-busting-drug-could-treat-various-brain-diseases